Optimizatsiya antigipertenzivnoyterapii u patsientov s khronicheskoyserdechnoy nedostatochnost'yuI-II funktsional'nykh klassov


Cite item

Full Text

Abstract

References

  1. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Сердечная Недостаточность. 2010; 1: 3-62.
  2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-42.
  3. Jessup M, Abraham WT, Casey DE et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
  4. McMurray JJV. Systolic heart failure. N Engl J Med 2010; 362: 228-38.
  5. Paulus WJ. Novel strategies in diastolic heart failure. Heart 2010; 96: 1147-53.
  6. Hernandez AF, Hammill BG, O'Connor CM et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol 2009; 53: 184-92.
  7. Al-Mohammad A, Mant J, Laramee P, Swain S; Chronic Heart Failure Guideline Development Group. Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance. BMJ 2010; 341: c4130. doi: 10.1136/bmj.c4130.
  8. Beckett NS, Peters R, Fletcher AE et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.
  9. Einhorn PT, Davis BR, Wright JT Jr. ALLHAT Cooperative Research Group. ALLHAT: still providing correct answers after 7 years. Curr Opin Cardiol 2010; 25: 355-65.
  10. Покровский В.М. Формирование ритма сердца в организме человека и животных. Краснодар: Кубань-Книга. 2007; с. 143.
  11. Покровский В.М., Пономарев В.В., Артюшков В.В. и др. Система для определения сердечно-дыхательного синхронизма у человека; Россия, патент 86860. 2009.
  12. Покровский В.М. Сердечно-дыхательный синхронизм в оценке регуляторно-адаптивных возможностей организма. Краснодар: Кубань-Книга. 2010; с. 244.
  13. Покровский В.М., Потягайло Е.Г., Абушкевич В.Г. и др. Сердечно-дыхательный синхронизм: выявление у человека, зависимость от свойств нервной системы и функциональных состояний организма. Успехи физиологических наук. 2003; 3: 68-77.
  14. Flather MD, Shibata MC, Coats AJS et al. FASTTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-25.
  15. van Veldhuisen DJ, Cohen SA, Bohm M et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009; 53: 2150-8.
  16. Packer M, Bristow MR, Cohn JN et al. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
  17. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia. New Zealand Heart Failure Research Collaborative Group. Lancet 1997; 349: 375-80.
  18. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭОТАР-Медиа, 2006.
  19. Беленков Ю.Н., Мареев В.Ю., Скворцов А.А. и др. Клинико-гемодинамические и нейрогуморальные эффекты длительной терапии бета-адреноблокатором бисопрололом больных с тяжелой хронической сердечной недостаточностью. Кардиология. 2003; 43 (10): 11-22.
  20. MERIT-HF Study Group. Effects of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized International Trialin Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.
  21. Wikstrand J, Warnold I, Tuomilehto J et al. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension 1991; 17 (4): 579-88.
  22. Rehnqvist N, Hjemdahl P, Billing E et al. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis study in Stockholm. Cardiologia 1995; 40 (12): 301.
  23. Savonitto S, Ardissiono D, Egstrup K et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 1996; 27 (2): 311-6.
  24. Chen ZM, Pan HC, Chen YP et al. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366 (9497): 1622-32.
  25. The MIAMI Trial Research Group: Metoprolol in acute myocardial infarction (MIAMI): A randomized placebo-controlled international trial. Eur Heart J 1985; 6 (3): 199-226.
  26. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 1997; 80 (9): 35-9.
  27. Pflugfelder PW, Baird MG, Tonkon MJ et al. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. J Am Coll Cardiol 1993; 22 (6): 1557-63.
  28. Beynon JH, Pathy MS. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heartfailure. Curr Med Res Opin 1997; 13 (10): 583-92.
  29. Acanfora D, Furgi G, Trojano L et al. Quinapril in patients with congestive heart failure: controlled trial versus captopril. Am J Ther 1997; 4 (5-6): 181-8.
  30. Zi M, Carmichael N, Lye M. The effect of quinapril on functional status of elderly patients with diastolic heart failure. Cardiovasc Drugs Ther 2003; 17: 133-9.
  31. Cleland JG, Tendera M, Adamus J et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-45.
  32. Pitt B, O'Neill B, Feldman R et al. QUIET Study Group. The Quinapril Ischemic Event Trial (QUIET) evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol 2001; 87: 1058-63.
  33. Беленков Ю.Н., Чазова И.Е., Мычка В.Б. Многоцентровое рандомизированное открытое исследование по изучению эффективности изменения образа жизни и терапии ингибиторами АПФ (квинаприлом) у больных ожирением и артериальной гипертонией (ЭКО). Артериальная гипертензия. 2003; 9 (6): 2009-11.
  34. Lopez-Sendon J, Swedberg K, McMurray JJ et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25: 1454-70.
  35. Willenheimer R, van Veldhuisen DJ, Silke B et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005; 112: 2426-35.
  36. Deedwania PC, Gottlieb S, Ghali JK et al. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004; 25: 1300-9.
  37. Erdmann E, Lechat P, Verkenne P et al. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 2001; 3: 469-79.
  38. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; (4): CD003566.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 83918 от 12.09.2022 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 83917 от 12.09.2022 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies